Anticancer activity of Hypericum mysorense

Raghu H Chandrashekhar, P. Vasanth Raj, Venkata J Rao, N. Udupa

Research output: Chapter in Book/Report/Conference proceedingConference contribution

1 Citation (Scopus)

Abstract

Methanolic extracts of different parts of Hyperium mysorense (HM) (Hypericaceae) namely aerial parts (HMA), flowering tops (HMF), leaf (HML), root (HMR) and stem (HMS) were screened for its in vitro and in vivo anti cancer activities. The short term toxicity studies were carried out against Ehrlich Ascitic Carcinoma (EAC) cells. Different concentrations of the HM extracts (1000 μg/ml, 500 μg/ml, 250 μg/ml, 125 μg/ml, 62.5 μg/ml and 31.25 μg/ml) were tested against EAC cells and the viability of the cells were estimated by trypan blue dye exclusion method. HMF and HML showed better activity with CTC50 value of 375.39 ± 11.83 and 393.64 ± 12.28 μg/ml, respectively. In vivo antitumor studies were carried out for active HMF and HML extracts using EAC induced Swiss Albino mice model. Two different concentrations of HMF and HML were tested in vivo and compared with 5-Flurouracil (5-FU) as standard. The animals of the tumor control group inoculated with EAC survived for a period of 18.66 ± 0.65 days. The treatment with the HMF at 100 and 400 mg/kg increased the Average life span (ALS) of animals by 22.33 ± 1.28 and 26.16 ± 1.75 (p<0.01) days, respectively. HML at a dose of 100 and 400 mg/kg increased the ALS of animals by 19.50 ± 1.73 and 23.50 ± 1.18 days, respectively. The standard 5-FU at 20 mg/kg, significantly (p<0.001) increased the life span to 30.33 ± 1.02 (p<0.001) days.

Original languageEnglish
Title of host publication2nd International Conference on Biomedical and Pharmaceutical Engineering, ICBPE 2009 - Conference Proceedings
DOIs
Publication statusPublished - 2009
Event2nd International Conference on Biomedical and Pharmaceutical Engineering, ICBPE 2009 - Singapore, Singapore
Duration: 02-12-200904-12-2009

Conference

Conference2nd International Conference on Biomedical and Pharmaceutical Engineering, ICBPE 2009
CountrySingapore
CitySingapore
Period02-12-0904-12-09

All Science Journal Classification (ASJC) codes

  • Biomedical Engineering
  • Medicine(all)

Fingerprint Dive into the research topics of 'Anticancer activity of Hypericum mysorense'. Together they form a unique fingerprint.

  • Cite this

    Chandrashekhar, R. H., Vasanth Raj, P., Rao, V. J., & Udupa, N. (2009). Anticancer activity of Hypericum mysorense. In 2nd International Conference on Biomedical and Pharmaceutical Engineering, ICBPE 2009 - Conference Proceedings [5384082] https://doi.org/10.1109/ICBPE.2009.5384082